Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry.

[1]  A. Phansalkar,et al.  Testing for hereditary thrombophilia: a retrospective analysis of testing referred to a national laboratory , 2008, BMC clinical pathology.

[2]  I. Greer,et al.  Is screening for thrombophilia cost-effective? , 2007, Current opinion in hematology.

[3]  Paolo Prandoni,et al.  The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies. , 2007, Haematologica.

[4]  A. Maestre,et al.  Venous thromboembolism in patients with renal insufficiency: findings from the RIETE Registry. , 2006, The American journal of medicine.

[5]  M. Greaves,et al.  Testing for thrombophilia: an evidence-based approach , 2006, Postgraduate Medical Journal.

[6]  M. Monreal,et al.  Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registry , 2006, Journal of thrombosis and haemostasis : JTH.

[7]  J. Rand,et al.  An Evaluation of Thrombophilia Screening in an Urban Tertiary Care Medical Center , 2006 .

[8]  J. Rand,et al.  An evaluation of thrombophilia screening in an urban tertiary care medical center: A "real world" experience. , 2006, American journal of clinical pathology.

[9]  M Greaves,et al.  Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. , 2006, Health technology assessment.

[10]  P. Langhorne,et al.  Screening for thrombophilia in high‐risk situations: a meta‐analysis and cost‐effectiveness analysis , 2005, British journal of haematology.

[11]  P. Pottier,et al.  Efficiency of Systematic Thrombophilia Screening in Idiopathic Venous Thrombosis: A Prospective Study in Internal Medicine , 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[12]  A. Nicolaides,et al.  Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence. , 2005, International angiology : a journal of the International Union of Angiology.

[13]  A. Nicolaides.  Chronic Venous Disease, Inflammation, and Daflon 500 mg , 2005, Angiology.

[14]  M. Greaves,et al.  Investigation and management of heritable thrombophilia , 2001, British journal of haematology.

[15]  T. Baglin,et al.  Laboratory testing for heritable thrombophilia: impact on clinical management of thrombotic disease , 2000, British journal of haematology.

[16]  A. Awidi,et al.  Hereditary thrombophilia among 217 consecutive patients with thromboembolic disease in Jordan , 1993, American journal of hematology.

[17]  K. Mcintyre.  Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis: Heijboer H, Brandjes DPM, Büller HR, Sturk A, Wouter ten Cate J. N Engl J Med 1990;323:1512–6 , 1991 .

[18]  A. Órfão,et al.  Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis , 1991, American journal of hematology.

[19]  H. Büller,et al.  Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. , 1990, The New England journal of medicine.

[20]  J. Heit.  Thrombophilia: common questions on laboratory assessment and management. , 2007, Hematology. American Society of Hematology. Education Program.

[21]  M. Monreal,et al.  Venous thromboembolism in very elderly patients: findings from a prospective registry (RIETE). , 2006, Haematologica.

[22]  M. Cushman.  Inherited risk factors for venous thrombosis. , 2005, Hematology. American Society of Hematology. Education Program.

[23]  Arnold Simanowitz,et al.  international consensus statement , 2000 .